Author

Alexander Carneiro-Figueira

Servicio Gallego de Salud

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Carlos Fernandez-LozanoiD· 2 shared Constance AlabertiD· 2 shared María D. MayániD· 2 shared Paula Carpintero-FernándeziD· 2 shared Susana B. BravoiD· 2 shared Vanesa ÁlvareziD· 2 shared Adrián Varela-VázqueziD· 1 shared Alejandro García-Yuste· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Carlos Fernandez-LozanoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 28, 2026

Dual Role of Cx43 in Enhancing CDK4/6 Inhibitor Response and Promoting the Elimination of Therapy-Induced Senescent Tumor Cells

Paula Carpintero-Fernández, Marta Barturen-Gómez, Vanesa Álvarez…·María D. Mayán

This paper identifies Cx43 as a target that enhances CDK4/6 inhibitor efficacy and promotes elimination of therapy-induced senescent tumor cells through senolytic agents.

DOI 10.64898/2026.10.26.761820

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedJul 4, 2025

Cx43 Enhances Response to BRAF/MEK Inhibitors by Reducing DNA Repair Capacity

Adrián Varela-Vázquez, Amanda Guitián‐Caamaño, Paula Carpintero-Fernández…·María D. Mayán

This study shows that Cx43 enhances the effectiveness of BRAF/MEKi by reducing DNA repair, leading to increased DNA damage and cellular senescence, and proposes a novel therapeutic approach using sEVs.

11 citations

humanexperimental assay

𝕏 PostBluesky